Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$150.95
+3.6%
$132.19
$55.92
$151.01
$4.65B1.4480,243 shs472,443 shs
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$80.81
+2.0%
$86.36
$73.11
$126.89
$5.48B0.111.01 million shs767,678 shs
Neogen Corporation stock logo
NEOG
Neogen
$4.77
-3.4%
$5.56
$3.87
$18.58
$1.07B1.843.29 million shs7.01 million shs
Progyny, Inc. stock logo
PGNY
Progyny
$20.79
-0.9%
$21.85
$13.39
$30.42
$1.80B1.321.71 million shs1.11 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+3.57%+4.24%+5.79%+41.60%+46.52%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
+2.05%+3.84%+9.41%-19.00%+2.16%
Neogen Corporation stock logo
NEOG
Neogen
-3.44%-15.43%-21.29%-43.55%-71.21%
Progyny, Inc. stock logo
PGNY
Progyny
-0.91%-1.28%+1.32%-3.26%-19.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
1.3969 of 5 stars
2.53.00.00.02.70.00.6
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
4.3329 of 5 stars
3.51.00.04.22.12.51.9
Neogen Corporation stock logo
NEOG
Neogen
3.6735 of 5 stars
3.33.00.00.01.83.32.5
Progyny, Inc. stock logo
PGNY
Progyny
1.7946 of 5 stars
2.21.00.00.03.22.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.90
Moderate Buy$138.60-8.18% Downside
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
3.00
Buy$130.5061.49% Upside
Neogen Corporation stock logo
NEOG
Neogen
2.50
Moderate Buy$9.0088.68% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.4512.82% Upside

Current Analyst Ratings Breakdown

Latest IRTC, LNTH, NEOG, and PGNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$122.00 ➝ $109.00
6/11/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$130.00 ➝ $160.00
5/22/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$130.00 ➝ $167.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/8/2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$127.00 ➝ $117.00
5/2/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$152.00 ➝ $139.00
5/2/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$133.00 ➝ $150.00
5/2/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$104.00 ➝ $130.00
5/2/2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$138.00 ➝ $151.00
4/22/2025
Neogen Corporation stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$6.40 ➝ $5.00
4/14/2025
Neogen Corporation stock logo
NEOG
Neogen
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $6.50
(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$591.84M8.14N/AN/A$2.90 per share52.05
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.53B3.65$7.24 per share11.16$15.65 per share5.16
Neogen Corporation stock logo
NEOG
Neogen
$906.00M1.14$0.99 per share4.82$14.52 per share0.33
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.53$0.34 per share60.79$4.96 per share4.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$113.29M-$3.14N/AN/AN/A-15.90%-101.04%-9.55%7/30/2025 (Estimated)
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$312.44M$3.5222.9612.81N/A16.55%36.99%20.55%7/30/2025 (Estimated)
Neogen Corporation stock logo
NEOG
Neogen
-$9.42M-$2.23N/A9.73N/A-53.56%2.69%1.82%7/29/2025 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5736.4731.982.214.33%10.90%7.20%8/5/2025 (Estimated)

Latest IRTC, LNTH, NEOG, and PGNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
5/7/2025Q1 2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.64$1.53-$0.11$1.02$377.37 million$372.76 million
5/1/2025Q1 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.89-$0.95-$0.06-$0.97$153.39 million$158.68 million
4/9/2025Q3 2025
Neogen Corporation stock logo
NEOG
Neogen
$0.12$0.10-$0.02-$0.05$225.27 million$221.00 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
N/AN/AN/AN/AN/A
Neogen Corporation stock logo
NEOG
Neogen
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
7.47
5.71
5.58
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
0.49
5.74
5.46
Neogen Corporation stock logo
NEOG
Neogen
0.33
3.91
2.45
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.39
2.39

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
99.06%
Neogen Corporation stock logo
NEOG
Neogen
96.73%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.68%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
2.00%
Neogen Corporation stock logo
NEOG
Neogen
1.13%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,00031.92 million31.71 millionOptionable
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
70069.19 million67.80 millionOptionable
Neogen Corporation stock logo
NEOG
Neogen
2,110217.04 million214.59 millionOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million77.66 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$150.95 +5.21 (+3.57%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$151.26 +0.31 (+0.21%)
As of 06/23/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Lantheus stock logo

Lantheus NASDAQ:LNTH

$80.81 +1.62 (+2.05%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$79.81 -1.00 (-1.23%)
As of 06/23/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Neogen stock logo

Neogen NASDAQ:NEOG

$4.77 -0.17 (-3.44%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$4.82 +0.06 (+1.15%)
As of 06/23/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared foods and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Progyny stock logo

Progyny NASDAQ:PGNY

$20.79 -0.19 (-0.91%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$21.06 +0.27 (+1.27%)
As of 06/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.